In a recent federal patent litigation, the role of the Licensing Expert Witness proved pivotal in determining the admissibility and weight of damages testimony. The case, Jackson v. NuVasive, Inc., D. Del. 2024, centered on allegations of patent infringement involving complex medical device technology and the calculation of reasonable royalty damages.
Background and Parties
The plaintiff, Jackson, asserted that NuVasive, Inc. infringed several patents related to spinal implant systems. The dispute focused not only on the technical merits of infringement but also on the appropriate measure of damages, specifically the reasonable royalty that would have been negotiated in a hypothetical licensing scenario.


